top of page



Prediction Markets, iGaming & Florida's Future Revenue Economy
North Carolina recently became the first state to explicitly incorporate federally regulated prediction markets into its state budget by imposing a 6 percent tax on operators' net trading fee revenue. While the immediate fiscal impact is expected to be modest, the policy significance is far greater. For the first time, a state has acknowledged prediction markets not simply as a regulatory issue, but as a legitimate component of its future revenue framework.

Policy & Regulation
Jul 154 min read


Hydrogen's Real Challenge Isn't Production—It's Distribution
The global conversation surrounding hydrogen has accelerated dramatically over the past several years. Governments are investing billions of dollars, utilities are evaluating new technologies, and private investors continue searching for the next breakthrough in clean energy. Yet much of the discussion overlooks a fundamental reality: Producing hydrogen is only part of the equation. Moving it safely, reliably, and economically at commercial scale is the far greater challeng

Policy & Regulation
Jul 84 min read


How New Infrastructure Incentives Are Reshaping Data Center Growth in Florida
Florida’s 2026 infrastructure and regulatory framework is not designed for incremental growth—it is engineered to attract hyperscale, AI-driven data center development. The shift is deliberate, and it is already reshaping where capital flows.

Policy & Regulation
Mar 283 min read


Florida's Data Center Policy Evolution
Today, roughly 9,000 data centers operate worldwide, with the United States hosting the largest share by a wide margin. Despite periodic claims that America is falling behind in digital infrastructure development, the reality is quite the opposite: the United States continues to dominate globally in the deployment and operation of large-scale data center capacity..

Policy & Regulation
Mar 144 min read


Moffitt Cancer Center Expands AI-Driven Immunotherapy Collaboration
Moffitt Cancer Center, Florida’s premier National Cancer Institute-designated facility, has expanded its partnership with biotechnology firm RyboDyn, Inc. to accelerate the development of advanced immunotherapies.

Policy & Regulation
May 21, 20251 min read
bottom of page
